Biosynex SA (EPA:ALBIO)
France · Delayed Price · Currency is EUR 0.9500
-0.0900 (-8.65%)
At close: Jan 28, 2026
Biosynex Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -70.99 | -43.33 | -36.95 | 15.66 | 104 | 31.37 | Upgrade |
Depreciation & Amortization | 24.69 | 5.37 | 12.2 | 21.36 | 2.04 | 7.25 | Upgrade |
Other Amortization | 10.5 | 7.31 | - | - | - | - | Upgrade |
Loss (Gain) From Sale of Assets | -0.88 | 0.57 | -0.02 | -0.01 | 0.03 | 0 | Upgrade |
Asset Writedown & Restructuring Costs | 20.25 | 8.8 | 1.26 | - | - | - | Upgrade |
Other Operating Activities | 0.22 | -1.74 | -0.66 | 5.19 | 3.18 | 0.2 | Upgrade |
Change in Other Net Operating Assets | 10.41 | 12.9 | 14.51 | -37.26 | 0.58 | -7.18 | Upgrade |
Operating Cash Flow | -5.81 | -10.12 | -9.65 | 4.95 | 109.83 | 31.64 | Upgrade |
Operating Cash Flow Growth | - | - | - | -95.50% | 247.17% | - | Upgrade |
Capital Expenditures | -4.35 | -4.84 | -39.54 | -37.77 | -19.02 | -9.12 | Upgrade |
Sale of Property, Plant & Equipment | 0.62 | 1.25 | 0.08 | 0.05 | 0.04 | 1.19 | Upgrade |
Cash Acquisitions | 0.52 | -1.01 | -16.05 | -9.74 | -10.96 | - | Upgrade |
Other Investing Activities | 0.05 | - | 0.71 | 0.69 | 0.97 | - | Upgrade |
Investing Cash Flow | -3.16 | -4.6 | -54.81 | -46.77 | -28.96 | -7.93 | Upgrade |
Long-Term Debt Issued | - | 0.16 | 22.41 | 17.66 | 24.25 | 7.26 | Upgrade |
Long-Term Debt Repaid | - | -4.25 | -14.83 | -5.57 | -7.42 | -1.25 | Upgrade |
Net Debt Issued (Repaid) | -2.6 | -4.09 | 7.58 | 12.09 | 16.83 | 6.01 | Upgrade |
Issuance of Common Stock | 8 | - | - | - | 19.43 | 4.45 | Upgrade |
Repurchase of Common Stock | - | - | -3.22 | -1.73 | -20.08 | - | Upgrade |
Common Dividends Paid | - | - | - | -20.44 | -1.94 | - | Upgrade |
Other Financing Activities | 3.37 | 3.29 | 0.81 | -0.73 | 0.16 | 0.15 | Upgrade |
Financing Cash Flow | 8.77 | -0.8 | 5.17 | -10.81 | 14.4 | 10.62 | Upgrade |
Miscellaneous Cash Flow Adjustments | 0 | - | - | 0 | - | - | Upgrade |
Net Cash Flow | -0.6 | -15.52 | -59.3 | -52.64 | 95.27 | 34.33 | Upgrade |
Free Cash Flow | -10.16 | -14.96 | -49.2 | -32.83 | 90.82 | 22.52 | Upgrade |
Free Cash Flow Growth | - | - | - | - | 303.29% | - | Upgrade |
Free Cash Flow Margin | -10.37% | -14.79% | -52.91% | -16.70% | 23.74% | 14.63% | Upgrade |
Free Cash Flow Per Share | -0.69 | -1.39 | -4.59 | -3.19 | 8.74 | 2.53 | Upgrade |
Levered Free Cash Flow | 2 | 1.48 | -42.49 | -26.31 | 72.74 | 26.9 | Upgrade |
Unlevered Free Cash Flow | 4.58 | 3.32 | -41.19 | -26 | 72.96 | 27.04 | Upgrade |
Change in Working Capital | 10.41 | 12.9 | 14.51 | -37.26 | 0.58 | -7.18 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.